Graham tells FDA to pull 'toxic' Ketek from market

Share this article:
FDA drug safety expert, whistleblower Dr. David Graham, has called on FDA officials to pull from the market Sanofi-Aventis' controversial antibiotic Ketek, saying it is as toxic, "if not more so," as three other drugs [Rezulin, Trovan and Duract] pulled from the market for liver problems. The FDA has already revised Ketek's labeling.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Legal/Regulatory


Does a health psychology approach hold the key to Rx adherence? In MM&M's latest Leadership Exchange Uncut eBook, industry stakeholders from the payer, provider, academic and pharma realms explore the "why" behind medicine taking. Access here.